Fig. 1From: A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritisOverview of Study Design. Visits 1 and 2 could have been combined if results from all assessments at Visit 1 were obtained at the time of Visit 1. If Visits 1 and 2 were conducted on the same day, visit procedures that were specific to Visit 2 were also conducted during Visit 1. The telephone call during the 2-week safety follow-up period was required for all patients (i.e., patients who completed the full 6Â months of treatment, patients who completed less than 6Â months of treatment, patients who discontinued early from the study, and patients who took at least 1 dose of study drug)Back to article page